DVAX

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change -0.03
Percentage change -0.23	%

Peers: JNJ PFE MRNA GILD BNTX AZN REGN NVAX VIR VXRT

| Held by: IJR IWM VTI XBI VXF IJT SPSM IWO IBB SLYG

Scroll to Statements

Index	RUT	P/E	99.46	EPS (ttm)	0.13	Insider Own	0.42%	Shs Outstand	131.34M	Perf Week	0.86%
Market Cap	1.70B	Forward P/E	51.16	EPS next Y	0.25	Insider Trans	0.00%	Shs Float	130.91M	Perf Month	-4.14%
Income	20.48M	PEG	-	EPS next Q	0.04	Inst Own	103.79%	Short Float	13.67%	Perf Quarter	16.23%
Sales	260.81M	P/S	6.53	EPS this Y	496.00%	Inst Trans	1.13%	Short Ratio	8.35	Perf Half Y	12.21%
Book/sh	5.19	P/B	2.50	EPS next Y	27.95%	ROA	2.01%	Short Interest	17.90M	Perf Year	-3.64%
Cash/sh	5.81	P/C	2.23	EPS next 5Y	-	ROE	3.18%	52W Range	9.74 - 15.01	Perf YTD	-7.30%
Dividend Est.	-	P/FCF	75.15	EPS past 5Y	54.52%	ROI	2.20%	52W High	-13.66%	Beta	1.34
Dividend TTM	-	Quick Ratio	12.34	Sales past 5Y	239.63%	Gross Margin	82.85%	52W Low	33.06%	ATR (14)	0.38
Dividend Ex-Date	-	Current Ratio	13.23	EPS Y/Y TTM	-67.40%	Oper. Margin	-2.85%	RSI (14)	59.32	Volatility	2.40% 3.22%
Employees	408	Debt/Eq	0.37	Sales Y/Y TTM	-27.79%	Profit Margin	7.85%	Recom	1.33	Target Price	23.80
Option/Short	Yes / Yes	LT Debt/Eq	0.37	EPS Q/Q	22.55%	Payout	-	Rel Volume	0.64	Prev Close	12.99
Sales Surprise	-4.20%	EPS Surprise	5.91%	Sales Q/Q	15.99%	Earnings	Nov 07 AMC	Avg Volume	2.14M	Price	12.96
SMA20	2.56%	SMA50	8.19%	SMA200	11.72%	Trades		Volume	1,379,591	Change	-0.23%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-01-24	Initiated	Goldman	Neutral	$20
Sep-27-22	Initiated	JMP Securities	Mkt Outperform	$22
Jan-06-22	Resumed	Goldman	Buy	$38
Aug-06-21	Initiated	Goldman	Buy	$19
Aug-07-20	Reiterated	H.C. Wainwright	Buy	$14 → $12
Aug-03-20	Reiterated	H.C. Wainwright	Buy	$12 → $14
Jun-15-20	Initiated	Evercore ISI	Outperform	$14
Oct-18-19	Initiated	H.C. Wainwright	Buy	$13
Jul-11-19	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$20
Feb-27-19	Reiterated	Cantor Fitzgerald	Overweight	$32 → $28
May-10-18	Upgrade	JP Morgan	Neutral → Overweight
Mar-08-18	Reiterated	Cantor Fitzgerald	Overweight	$25 → $27
Feb-14-18	Downgrade	JP Morgan	Overweight → Neutral
Sep-25-17	Reiterated	RBC Capital Mkts	Outperform	$26 → $28
Sep-15-17	Initiated	Cantor Fitzgerald	Overweight	$24
Jul-31-17	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$7 → $26
Jul-31-17	Upgrade	JP Morgan	Neutral → Overweight
May-09-17	Reiterated	RBC Capital Mkts	Sector Perform	$6 → $7
Apr-28-16	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$48 → $17
Apr-27-16	Downgrade	JP Morgan	Overweight → Neutral

Show Previous Ratings

Nov-27-24 09:55AM	Does Dynavax Technologies (DVAX) Have the Potential to Rally 93.52% as Wall Street Analysts Expect? (Zacks)
Nov-26-24 04:05PM	Dynavax to Present at the 7th Annual Evercore HealthCONx Conference (PR Newswire)
Nov-25-24 09:03AM	Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't? (Zacks)
Nov-19-24 08:50AM	Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode (Insider Monkey)
Nov-11-24 12:00PM	Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why (Zacks)
09:55AM	Loading…
09:55AM	Wall Street Analysts Predict an 88.32% Upside in Dynavax Technologies (DVAX): Here's What You Should Know (Zacks)
08:00AM	Dynavax Announces $100 Million Accelerated Share Repurchase Program (PR Newswire)
Nov-08-24 12:02PM	Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ... (GuruFocus.com) +8.24%
Nov-07-24 11:15PM	Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript (Motley Fool)
05:25PM	Dynavax Technologies (DVAX) Q3 Earnings Surpass Estimates (Zacks)
04:18PM	Dynavax Technologies: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates (PR Newswire)
04:01PM	Dynavax Announces $200 Million Share Repurchase Program (PR Newswire)
Nov-01-24 06:33PM	Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors (Barrons.com)
Oct-29-24 08:30AM	Dynavax Adopts Limited-Duration Stockholder Rights Plan (PR Newswire)
09:08PM	Loading…
Oct-24-24 09:08PM	Deep Track Capital, LP Reduces Stake in Dynavax Technologies Corp (GuruFocus.com)
04:10PM	Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024 (PR Newswire)
Oct-16-24 01:04PM	State Street Corp's Strategic Reduction in Dynavax Technologies Holdings (GuruFocus.com)
Oct-09-24 05:07PM	Dynavax Technologies Corp (DVAX) Q2 2024 Earnings Call Highlights: Record HEPLISAV-B Sales and ... (GuruFocus.com)
Sep-20-24 06:39PM	Lennar, Bitdeer, and More Stocks See Action From Activist Investors (Barrons.com)
Sep-16-24 07:02PM	Deep Track Capital, LP Increases Stake in Dynavax Technologies Corp (GuruFocus.com)
Sep-12-24 01:13AM	Federated Hermes, Inc. Reduces Stake in Dynavax Technologies Corp (GuruFocus.com)
Sep-05-24 08:30AM	Lantheus Appoints Julie Eastland as New Board Member (GlobeNewswire)
Aug-09-24 09:55AM	How Much Upside is Left in Dynavax Technologies (DVAX)? Wall Street Analysts Think 135.98% (Zacks)
Aug-06-24 11:30PM	Dynavax Technologies (DVAX) Q2 2024 Earnings Call Transcript (Motley Fool) +6.97%
07:10PM	Dynavax Technologies (DVAX) Tops Q2 Earnings Estimates (Zacks)
06:11PM	Dynavax Technologies: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates (PR Newswire)
Jul-23-24 04:00PM	Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 (PR Newswire)
Jun-28-24 04:32AM	Dynavax doses first subject in Phase I/II shingles vaccine trial (Clinical Trials Arena)
04:09PM	Loading…
Jun-27-24 04:09PM	Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program (PR Newswire)
May-28-24 04:18PM	Dynavax to Present at Upcoming Investor Conferences (PR Newswire)
May-14-24 09:59AM	Dynavax Technologies Notified by US FDA That Application for Four-Dose Course of Hepatitis B Vaccine Lacks Sufficient Data (MT Newswires)
08:55AM	UPDATE 1-US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine (Reuters)
08:30AM	Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B Regimen for Adults on Hemodialysis in the U.S. (PR Newswire)
May-10-24 01:43PM	Dynavax Technologies Corp (DVAX) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses ... (GuruFocus.com)
May-09-24 01:58PM	Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call Transcript (Insider Monkey) -5.49%
03:40AM	Dynavax Technologies Corp (DVAX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue ... (GuruFocus.com)
02:15AM	Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript (Motley Fool)
May-08-24 08:59PM	DVAX Stock Earnings: Dynavax Technologies Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:20PM	Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:17PM	Dynavax Technologies: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates (PR Newswire)
Apr-24-24 04:05PM	Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 (PR Newswire)
Apr-21-24 10:39AM	11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Mar-04-24 11:53PM	Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX) (GuruFocus.com)
08:28PM	11 Best Small Cap Pharma Stocks to Invest In (Insider Monkey)
Feb-27-24 06:54PM	Dynavax to Present at TD Cowen's 44th Annual Health Care Conference (PR Newswire)
Feb-23-24 10:34AM	Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:38AM	Q4 2023 Dynavax Technologies Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-22-24 08:00PM	Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript (Motley Fool)
05:15PM	Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4 (Zacks)
04:44PM	Dynavax Technologies Corp (DVAX) Reports Robust Revenue Growth and Market Leadership in 2023 (GuruFocus.com)
04:01PM	Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance (PR Newswire)
Feb-08-24 04:15PM	Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024 (PR Newswire)
Jan-08-24 10:58PM	3 Stocks Set to Soar 68% to 200% Higher (InvestorPlace) -5.22%
09:00AM	Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights (PR Newswire)
Jan-05-24 08:50AM	Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
03:03AM	Insider Sell: Dynavax Technologies Corp President & COO David Novack Sells 9,000 Shares (GuruFocus.com)
Jan-03-24 06:33PM	Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-05-23 09:55AM	Can Dynavax Technologies (DVAX) Climb 91.59% to Reach the Level Wall Street Analysts Expect? (Zacks)
Nov-24-23 09:40AM	Is Dynavax Technologies (DVAX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Nov-20-23 05:04PM	Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-07-23 09:40AM	Is Dynavax Technologies (DVAX) Outperforming Other Medical Stocks This Year? (Zacks)
Nov-04-23 09:02AM	Insider Sell: President & COO David Novack Sells 20,000 Shares of Dynavax Technologies Corp (GuruFocus.com)
Nov-03-23 12:28PM	Intra-Cellular (ITCI) Q3 Earnings Top, Product Sales View Raised (Zacks)
10:46AM	Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2023 Earnings Call Transcript (Insider Monkey)
05:31AM	Dynavax Technologies (DVAX) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-02-23 06:22PM	Dynavax Technologies Corp (DVAX) Reports 66% YoY Increase in Q3 2023 HEPLISAV-B Revenue (GuruFocus.com)
04:39PM	Dynavax Technologies: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance (PR Newswire)
11:23AM	Corcept (CORT) Beats on Q3 Earnings, Raises '23 Sales View (Zacks)
Nov-01-23 12:03PM	Amarin (AMRN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Oct-30-23 10:00AM	Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-26-23 04:15PM	Dynavax to Report Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023 (PR Newswire)
12:00PM	Alkermes (ALKS) Down Despite Q3 Earnings & Revenue Beat (Zacks)
10:02AM	Dynavax Technologies (DVAX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-24-23 07:45AM	Dynavax (DVAX) to Report Q3 Earnings: Will It Beat Estimates? (Zacks)
Oct-19-23 01:15PM	Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference (PR Newswire)
06:32AM	Is it a Good Idea to Invest in Dynavax (DVAX) Stock Now? (Zacks)
Oct-16-23 09:55AM	Wall Street Analysts See an 80.27% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High? (Zacks)
08:50AM	Here's Why Momentum in Dynavax Technologies (DVAX) Should Keep going (Zacks)
Oct-12-23 10:42AM	Tempest (TPST) Up as First-Line Liver Cancer Study Meets Goals (Zacks)
Oct-11-23 09:24AM	Novo Nordisk (NVO) Up on Positive Kidney Outcomes Study Update (Zacks)
Oct-05-23 05:01AM	Insider Sell: President & COO David Novack Sells 40,000 Shares of Dynavax Technologies Corp (GuruFocus.com)
Sep-29-23 09:55AM	Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 73.92%: Read This Before Placing a Bet (Zacks)
08:50AM	Here's What Could Help Dynavax Technologies (DVAX) Maintain Its Recent Price Strength (Zacks)
Sep-28-23 11:18AM	Crinetics (CRNX) Stock Surges 70% in a Month: Here's Why (Zacks)
10:48AM	Viatris (VTRS) Gets FDA Nod for Pupil Dilation Reversal Agent (Zacks)
Sep-26-23 11:49AM	Unveiling Dynavax Technologies (DVAX)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-21-23 09:19AM	Atara (ATRA) Up 11% on Regulatory Update From Blood Cancer Study (Zacks)
Sep-20-23 07:51AM	Gilead's (GILD) Veklury Gets CHMP Nod in Damaged Liver Patients (Zacks)
Sep-18-23 09:16AM	GSK's Momelotinib Gets FDA Nod for Myelofibrosis-Related Anemia (Zacks)
Sep-14-23 09:36AM	Alnylam's (ALNY) Onpattro sNDA Gets FDA Advisory Committee Nod (Zacks)
Sep-12-23 08:26AM	Aquestive's (AQST) Libervant Accepted for FDA Review, Stock Up (Zacks)
07:54AM	Bicycle (BCYC) to Begin Pivotal Bladder Cancer Study, Stock Up (Zacks)
Sep-11-23 12:31PM	J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe (Zacks)
08:21AM	Codexis (CDXS) Transfers Leasing Rights to Vaxcyte, Stock Up (Zacks)
Sep-08-23 07:06PM	Merck's (MRK) Ebola Vaccine Gets Approval for Kids in Europe (Zacks)
Sep-07-23 08:43AM	J&J (JNJ) to End Pulmonary Hypertension Study on Opsumit (Zacks)

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CANO FRANCIS	Director	May 31 '24	Sale	11.93	3,615	43,127	36,905	Jun 03 05:37 PM
CANO FRANCIS	Director	May 24 '24	Option Exercise	5.90	7,500	44,250	44,405	May 28 08:18 PM
Burgess Justin	Chief Accounting Officer	Mar 01 '24	Option Exercise	10.45	7,101	74,232	20,526	Mar 04 05:25 PM
Burgess Justin	Chief Accounting Officer	Mar 01 '24	Sale	12.78	20,526	262,322	0	Mar 04 05:25 PM
Janssen Robert	SVP and CMO	Jan 04 '24	Option Exercise	9.41	1,500	14,115	51,425	Jan 08 06:48 PM
Janssen Robert	SVP and CMO	Jan 04 '24	Sale	15.00	1,500	22,500	49,925	Jan 08 06:48 PM
Novack David F	President & COO	Jan 02 '24	Option Exercise	5.42	9,000	48,780	12,187	Jan 04 07:04 PM
Novack David F	President & COO	Jan 02 '24	Sale	14.45	9,000	130,050	3,187	Jan 04 07:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Dynavax Technologies Corp

Upgrade your FINVIZ experience